T

TScan Therapeutics

124 employees

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$100M

from 16 investors over 16 rounds

T

TScan Therapeutics raised $60M on September 12, 2022

Investors: K2 HealthVentures

T

TScan Therapeutics raised $100M on January 25, 2021

Investors: 6 Dimensions Capital, GV, Longwood Fund, Pitango Venture Capital, Bessemer Venture Partners and RA Capital Management, L.P.

T

TScan Therapeutics raised $35M on January 10, 2020

Investors: Astellas Venture Capital L.L.C., 6 Dimensions Capital, Pitango Venture Capital, Longwood Fund, Bessemer Venture Partners and GV

T

TScan Therapeutics raised undisclosed on July 24, 2019

Investors: GV, Longwood Fund and Bessemer Venture Partners

FAQ